News & Articles

Yao Chen of Sanofi shares how her team achieves sensitivity, specificity, precision, and robustness in protein biomarker detection

Myalgic encephalomyelitis study identifies over 250 core genes, shared biology with long COVID, and dozens of drug repurposing opportunities

University of Cambridge researcher spotlights a novel radiotracer during ELRIG Drug Discovery 2025

Enables ultra-low variant detection across a range of key measurable residual disease targets in acute myeloid leukaemia, including very large FLT3-ITDs

Dr. Richard Knight, medical director of transplant diagnostics at Thermo Fisher Scientific explores personalized, non‑invasive approaches designed to improve transplant success

Quanterix Director of Medical Affairs discusses the advances revolutionizing Alzheimer’s diagnosis and care

Neuro-Bio is creating a first-of-its-kind diagnostic, targeting a novel biomarker in Alzheimer’s Disease

This assay allows for the quantitative measurement of soluble sTREM2 in human cerebrospinal fluid and blood within just 35 minutes

Radiometer’s blood gas and immunoassay POC analysers deliver critical parameters enabling critical care teams to make quick decisions fast

Accelerated platform delivers validated biomarkers with ready-to-use Optimer ligands in months rather than years

Revvity’s Euroimmun shares insights on the role of amyloid-beta, tau, neurofilament and APOE genotype in Alzheimer’s disease diagnostics

Join experts as they discuss the significant hurdles in spatial proteomics and how innovative tools such as the EVOS S1000 Spatial Imaging System are set to redefine research capabilities in this rapidly evolving field

From concept to clinic, NExT gives researchers and developers access to Fujirebio’s unmatched expertise in neurological biomarker testing

Company highlights expanded capabilities following Akoya Biosciences Acquisition and Simoa technology included in more than 55 posters and oral presentations at the annual conference demonstrating its impact on neurodegenerative disease research

The test operates using the company’s fully automated Lumipulse G1200 instrument system

Crown Bioscience to deliver clinical-grade testing, further strengthening its support for clients' clinical and translational drug development efforts

By developing rapid, accurate, and cost-effective lateral flow tests for prostate cancer, Valley Diagnostics aims to make early diagnosis more accessible and reliable

Grifols and IBL, a Tecan company, seek to revolutionize clinical diagnostics with a future high-sensitivity, multiplexed immunoassay platform

Agreement represents a significant step towards bringing Sona’s bTB rapid test to the market at scale

The use of protein biomarkers in oncology is growing rapidly and offers real hope to patients with hard-to-treat cancers

The first cleared troponin assay in the U.S. for longer-term prognostic insights

Experts from Chan Zuckerberg Initiative, FDA, AbbVie, Elsevier, Penn Medicine, Takeda and others discuss patient-centricity, data standards, and copyright

Research results highlight how the Idylla™ System allows for the analysis of small biological samples, including cytological specimens, giving healthcare providers critical information within hours so they can make timely treatment decisions